Regression of BCC following immunosuppression withdrawal in a renal transplant recipient [9]

Clinical and Experimental Dermatology

Volumn 31, Issue 5, 2006, Pages 717-718

  Rawlins, J ^a   Platt, A ^a   Gowda, P ^b  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b PRINCESS ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

AGED; BASAL CELL CARCINOMA; CASE REPORT; CHRONIC KIDNEY FAILURE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY POLYCYSTIC DISEASE; LETTER; MALE; ORGAN TRANSPLANTATION; PLASTIC SURGERY; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; SKIN TUMOR; ULTRAVIOLET RADIATION;

AGED; CARCINOMA, BASAL CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; NEOPLASM REGRESSION, SPONTANEOUS; NOSE NEOPLASMS; TACROLIMUS;

EID: 33746148887     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02197.x     Document Type: Letter

References (5)

1. Wong C, Strange R, Lear J. Basal cell carcinoma. Br Med J 2003; 327: 794-8.
2. Kanitakis J, Alhaj-Ibrahim L, Euvrard S et al. Basal cell carcinomas developing in solid organ transplant recipients. Arch Dermatol 2003; 139: 1133-7.
3. O'Donovan P, Perrett C, Zhang X et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-4.
4. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Eng J Med 2003; 348: 1681-91.
5. Remuzzi G, Lesti M, Gotti E et al. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomized trial. Lancet 2004; 364: 503-12.